These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League. Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P; J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027 [TBL] [Abstract][Full Text] [Related]
47. Relationship between arterial hypertension and renal damage in chronic kidney disease: insights from ABPM. Paoletti E; Bellino D; Amidone M; Rolla D; Cannella G J Nephrol; 2006; 19(6):778-82. PubMed ID: 17173252 [TBL] [Abstract][Full Text] [Related]
48. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737 [TBL] [Abstract][Full Text] [Related]
49. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [TBL] [Abstract][Full Text] [Related]
50. Circadian blood pressure changes in untreated children with kidney disease and conserved renal function. Lingens N; Freund M; Seeman T; Witte K; Lemmer B; Schärer K Acta Paediatr; 1997 Jul; 86(7):719-23. PubMed ID: 9240879 [TBL] [Abstract][Full Text] [Related]
51. [Practical guide for interpretation and comprehension of ambulatory blood pressure measurement]. Bibbo E; Muggli F; Pechère-Bertschi A Rev Med Suisse; 2008 Sep; 4(170):1910, 1912-6. PubMed ID: 18847119 [TBL] [Abstract][Full Text] [Related]
52. [What are the clinical implications of nocturnal blood pressure?]. Burnier M Rev Med Suisse; 2007 Sep; 3(124):2007-10. PubMed ID: 17955828 [TBL] [Abstract][Full Text] [Related]
54. Prognostic value of nocturnal blood pressure reduction in resistant hypertension. Muxfeldt ES; Cardoso CR; Salles GF Arch Intern Med; 2009 May; 169(9):874-80. PubMed ID: 19433699 [TBL] [Abstract][Full Text] [Related]
55. Does diurnal variation in blood pressure exist in CAPD patients? Goldsmith DJ Nephrol Dial Transplant; 1994; 9(11):1698-9. PubMed ID: 7870371 [No Abstract] [Full Text] [Related]
56. Mechanisms and consequences of sympathetic hyperactivity in renal disease. Amann K; Veelken R Clin Nephrol; 2003 Jul; 60 Suppl 1():S81-92. PubMed ID: 12940538 [TBL] [Abstract][Full Text] [Related]
57. [Reduced nocturnal systolic blood pressure dip in obese children]. Ruiz Pons M; García Nieto V; García MG; García Mérida M; Valenzuela Hdez C; Aguirre-Jaime A Nefrologia; 2008; 28(5):517-24. PubMed ID: 18816210 [TBL] [Abstract][Full Text] [Related]
58. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375 [TBL] [Abstract][Full Text] [Related]
59. Variations in levels of blood pressure: of prognostic value or not? Jafar TH; Ebrahim SB Am J Kidney Dis; 2008 Oct; 52(4):638-41. PubMed ID: 18805343 [No Abstract] [Full Text] [Related]
60. [Resistant hypertension in non-dialysis chronic kidney disease]. Borrelli S; Minutolo R; Calabria M; Grimaldi M; Di Pietro R; Donnarumma G; D'Angio' PL; Conte G; De Nicola L G Ital Nefrol; 2009; 26(3):328-37. PubMed ID: 19554530 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]